BioSpace News Archive

According to Transparency Market Research’s latest report on the global antibacterial drugs market for the historical period 2017–2018 and forecast period 2019–2027, high prevalence of infectious diseases, increase in research and developmental activities, and increase in initiatives by government in healthcare sector are the factors projected to drive the global antibacterial drugs market during the forecast period

Transparency Market Research has published a new report titled, “Collagen Peptide and Gelatin Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027”.

Transparency Market Research has published a new report titled, ‘Geriatric Medicine Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027’.

Increasing incidence of various neurological disorders, such as Parkinson’s disease, strokes, multiple sclerosis usually causes disability in terms of movement in patients.

BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biotechnology company focused on developing and commercializing innovative medicines worldwide, today announced that the company’s ordinary shares, which trade on the Hong Kong Stock Exchange, will be included in the Shanghai-Hong Kong Stock Connect and Shenzhen-Hong Kong Stock Connect programs, effective on September 7, 2020. In addition, BeiGe

HMS Holdings Corp. (Nasdaq: HMSY) today announced its management team is scheduled to participate in the Baird 2020 Global Healthcare Conference on Wednesday, September 9, 2020, at 2:35 p.m. EDT. Management will deliver an HMS overview presentation and participate in a virtual fireside chat session. A webcast and copy of the presentation will be available on the Company’s website at http://investor.hms.com/events-and-presentations .

The Christopher & Dana Reeve Foundation Paralysis Resource Center announces grant funding opportunities through its 2nd Cycle 2020 Direct Effect Quality of Life and High Impact Priority Quality of Life grants initiatives.

According to Coherent Market Insights, the Asia gout disease treatment market is estimated to be valued at US$ 643.5 Mn in 2020 and is expected to exhibit a CAGR of 9.1% during the forecast period (2020-2027). Key Trends and Analysis of the Asia Gout Disease Treatment Market: Market players are focused on adoption of inorganic growth strategies such as acquisitions, collaborations, and partnerships to strengthen

Yiling Pharmaceutical on Friday issued a notice that it had received a certificate of drug registration granted by the Pharmaceutical and Herbal Medicine Registration and Control Administration of Kuwait that certified its drug - Lianhua Qingwen Capsules - as a herbal medicine to be registered in Kuwait.

On August 25, 111, Inc., a company dedicated to digitally connecting patients with drugs and healthcare services in China, and Guangzhou Baiyunshan Pharmaceutical Sales Co., Ltd., an affiliate of Guangzhou Pharmaceuticals Corporation, signed a strategic cooperation agreement in Shanghai.